NMN + Curcumin Stack: Evidence and Liver Safety

Pairing NMN with curcumin is popular in longevity circles: NMN raises NAD+ and curcumin is used for inflammation and joint comfort. No human trial has tested them together, so any benefit is assumed, not shown. This page covers the evidence for each ingredient, the one safety signal you should not skip (turmeric-associated liver injury), and a cautious way to try the stack.

Evidence grade: D for the combination (no human trials). Grade C for NMN raising blood NAD+. Grade B/C for curcumin and turmeric extracts easing osteoarthritis symptoms (small to moderate RCTs, pooled in meta-analysis).

Key takeaways

• The best-supported use of curcumin is joint pain from osteoarthritis, not "anti-ageing". In a meta-analysis of RCTs, turmeric or curcumin lowered pain scores against placebo and performed similarly to pain medicine (Daily 2016).
• NMN raises blood NAD+ in short trials, but no outcome trials show it slows ageing.
• The US Drug-Induced Liver Injury Network has documented turmeric-associated liver injury, including one death. Stop and seek care if you notice jaundice, dark urine or unusual fatigue.
• There is no known direct NMN–curcumin interaction, but curcumin does interact with some medicines (see below).

As an Amazon Associate, Stacking Years earns from qualifying purchases.

Why people combine them

NMN refills NAD+, which falls with age. Curcumin targets inflammatory signaling, which also rises with age ("inflammaging"). The pairing makes sense on paper: two different mechanisms with no shared side effects. Whether the combination does more than either alone has never been measured.

Curcumin: what it is actually good for

Daily et al. (2016, *J Med Food*) pooled 8 RCTs of turmeric extracts or curcumin for joint arthritis. Pain scores (VAS) fell by about 2 points against placebo, WOMAC scores improved, and results were similar to pain medicine in the head-to-head studies (PMID 27533649). The trials were small and short, with low-to-moderate risk of bias. Evidence for curcumin as a general longevity agent in humans is much weaker.

Absorption matters. Plain curcumin is poorly absorbed. Most clinical products use enhanced forms, such as phytosome (Meriva) or formulations with turmeric oils or piperine. Doses in trials are usually around 500–1,000 mg/day of the extract as labelled.

NMN: the short version

In a 60-day RCT of 80 healthy middle-aged adults, 300–900 mg/day of NMN raised blood NAD+ and improved six-minute walk distance against placebo (Yi 2023, PMID 36482258). In prediabetic women, 250 mg/day improved muscle insulin sensitivity (Yoshino 2021, PMID 33888596). These are short, small trials of surrogate markers.

The safety signal: turmeric and the liver

Halegoua-DeMarzio et al. (2023, *Am J Med*) described 10 adjudicated turmeric-associated liver injury cases in the US DILIN registry. All were enrolled since 2011, six since 2017. Five patients were hospitalized and one died of acute liver failure. Seven carried the HLA-B*35:01 gene variant, and three of the products also contained piperine (PMID 36252717). Injury is rare, but it is the main reason to be cautious:

• Avoid curcumin if you have liver disease or previous drug-induced liver injury.
• Be extra careful with piperine (black pepper) "enhanced" products, which raise absorption.
• Consider a baseline and a 6–8-week liver panel if you plan long-term use.

Interactions to check

Curcumin may add to the effect of blood thinners and antiplatelet drugs. It may also affect diabetes medicines and some drugs cleared by the liver. Ask your pharmacist if you take any regular medication.

A cautious way to try the stack

Product notes

Choose NMN with third-party purity testing that names its raw material, such as Toniiq NMN (Uthever). For curcumin, choose a named enhanced-absorption form (for example curcumin phytosome / Meriva) with the curcuminoid dose stated on the label. No product here is ranked or star-rated. See the NMN and NAD+ guide for NMN dosing and NR alternatives.